The Enterprise Value as of August 2024 (TTM) for NGM Biopharmaceuticals, Inc. (NGM) is 69.72M

According to NGM Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 69.72M. This represents a change of -42.49% compared to the average of 121.22M of the last 4 quarters.

NGM Biopharmaceuticals, Inc. (NGM) Historical Enterprise Value (quarterly & annually)

How has NGM Enterprise Value performed in the past?

The mean historical Enterprise Value of NGM Biopharmaceuticals, Inc. over the last ten years is 823.27M. The current 69.72M Enterprise Value has changed 746.83% with respect to the historical average. Over the past ten years (40 quarters), NGM's Enterprise Value was at its highest in in the March 2021 quarter at 2.06B. The Enterprise Value was at its lowest in in the December 2017 quarter at -25593000.00.

NGM Biopharmaceuticals, Inc. (NGM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NGM Biopharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NGM Biopharmaceuticals, Inc. (NGM) Average Enterprise Value

How has NGM Enterprise Value performed in the past?

The current Enterprise Value of NGM Biopharmaceuticals, Inc. (NGM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NGM Biopharmaceuticals, Inc. (NGM) Enterprise Value vs. Peers

How is NGM’s Enterprise Value compared to its peers?

NGM Biopharmaceuticals, Inc.’s Enterprise Value is greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (171.51M), greater than Achilles Therapeutics plc (-61068820.00), greater than NextCure, Inc. (25.04M), less than Assembly Biosciences, Inc. (90.35M), less than Erasca, Inc. (689.13M), less than Century Therapeutics, Inc. (138.60M), less than Keros Therapeutics, Inc. (1.58B), less than Monte Rosa Therapeutics, Inc. (284.72M), less than Nkarta, Inc. (340.55M), less than Lyell Immunopharma, Inc. (226.32M), less than Generation Bio Co. (210.95M), less than Sana Biotechnology, Inc. (1.08B), greater than Kezar Life Sciences, Inc. (30.16M), less than Mineralys Therapeutics, Inc. (490.57M), less than Foghorn Therapeutics Inc. (318.59M), less than C4 Therapeutics, Inc. (369.73M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Prelude Therapeutics Incorporated (257.24M), less than Rezolute, Inc. (237.24M),

Build a custom stock screener for NGM Biopharmaceuticals, Inc. (NGM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NGM Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NGM Biopharmaceuticals, Inc. (NGM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NGM Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.